Mucocutaneous side effects of gefitinib
Background: Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein which is expressed in various tissues. Aberrant EGFR signaling plays an important role in carcinogenesis. Gefitinib, an EGFR inhibitor, is a promising drug in treatment of various malignancies. Awareness about the va...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| coleção: | Muller Journal of Medical Sciences and Research |
| Assuntos: | |
| Acesso em linha: | http://www.mjmsr.net/article.asp?issn=0975-9727;year=2021;volume=12;issue=2;spage=86;epage=89;aulast=Thekkath |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|